Frontiers in Pharmacology | Gastrointestinal and Hepatic Pharmacology

Original Research

Published on 08 Aug 2023

The immune and metabolic treatment approach of using testosterone on mice models of liver injury

in Gastrointestinal and Hepatic Pharmacology

Johnny Amer
Ahmad Salhab
Hadeel Snobar
Yazan Alhabil

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1219709

3,025 views
2 citations

Editorial

Published on 07 Aug 2023

Editorial: Hepatic insulin resistance and related obesity: highlighting the ameliorative role of nutraceuticals, dietary intervention, and pharmaceuticals

in Gastrointestinal and Hepatic Pharmacology

Nehal M. Ramadan
Priscila O. Barbosa
Nada F. Abo El-Magd
Salma M. Eraky
Mohammed M. H. Al-Gayyar

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1266168

1,461 views

Original Research

Published on 07 Aug 2023

Mitigation of acetaminophen-induced liver toxicity by the novel phosphatidylinositol 3-kinase inhibitor alpelisib

in Gastrointestinal and Hepatic Pharmacology

Mohamed E. Shaker
Hesham A. M. Gomaa
Sara H. Hazem
Mohamed A. Abdelgawad
Mohamed El-Mesery
Ahmed A. Shaaban

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1212771

3,011 views
2 citations

Review

Published on 04 Aug 2023

Gut microbiota in alcohol-related liver disease: pathophysiology and gut-brain cross talk

in Gastrointestinal and Hepatic Pharmacology

Lin Zhu
Yixuan Wang
Calvin Q. Pan
Huichun Xing

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1258062

4,146 views
11 citations

Review

Published on 04 Aug 2023

Advances in the study of acetaminophen-induced liver injury

in Gastrointestinal and Hepatic Pharmacology

Xinghui Li
Jiaqi Ni
Li Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1239395

9,250 views
14 citations

Perspective

Published on 03 Aug 2023

COVID-19 vaccination-related autoimmune hepatitis—a perspective

in Gastrointestinal and Hepatic Pharmacology

Consolato M. Sergi

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1190367

4,357 views
4 citations

Review

Published on 01 Aug 2023

Oxaliplatin-induced peripheral neurotoxicity in colorectal cancer patients: mechanisms, pharmacokinetics and strategies

in Gastrointestinal and Hepatic Pharmacology

Fang Cheng
Ruoqi Zhang
Chen Sun
Qian Ran
Cuihan Zhang
Changhong Shen
Ziqing Yao
Miao Wang
Lin Song
Cheng Peng

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1231401

11,357 views
17 citations

Original Research

Published on 31 Jul 2023

Calebin A targets the HIF-1α/NF-κB pathway to suppress colorectal cancer cell migration

in Gastrointestinal and Hepatic Pharmacology

Aranka Brockmueller
Sosmitha Girisa
Mahzad Motallebi
Ajaikumar B. Kunnumakkara
Mehdi Shakibaei

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1203436

3,023 views
9 citations

Correction

Published on 26 Jul 2023

Corrigendum: Revealing the mechanism of Huazhi Rougan granule in the treatment of nonalcoholic fatty liver through intestinal flora based on 16S rRNA, metagenomic sequencing and network pharmacology

in Gastrointestinal and Hepatic Pharmacology

Yingying Liu
Yingying Tan
Jiaqi Huang
Chao Wu
Xiaotian Fan
Antony Stalin
Shan Lu
Haojia Wang
Jingyuan Zhang
Fanqin Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1243304

1,398 views

Original Research

Published on 24 Jul 2023

Inulin ameliorates metabolic syndrome in high-fat diet-fed mice by regulating gut microbiota and bile acid excretion

in Gastrointestinal and Hepatic Pharmacology

Shaoxiong Huang
Shiliang Dong
Lizhen Lin
Qiming Ma
Mengping Xu
Limei Ni
Qitong Fan

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1226448

4,516 views
12 citations

Systematic Review

Published on 19 Jul 2023

Non-selective beta-blockers and the incidence of hepatocellular carcinoma in patients with cirrhosis: a meta-analysis

in Gastrointestinal and Hepatic Pharmacology

Xinyi He
Zimo Zhao
Xi Jiang
Yan Sun

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1216059

3,393 views
10 citations

Original Research

Published on 19 Jul 2023

Neuropsychiatric disorders in chronic hepatitis C patients after receiving interferon or direct-acting antivirals: a nationwide cohort study

in Gastrointestinal and Hepatic Pharmacology

Yu Fang
Chung-Yu Chen
Hsien-Chung Yu
Pei-Chin Lin

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1191843

1,772 views
6 citations

Review

Published on 17 Jul 2023

Proton pump inhibitors may enhance the risk of digestive diseases by regulating intestinal microbiota

in Gastrointestinal and Hepatic Pharmacology

Liang Tian
Chongfei Huang
Wenkang Fu
Long Gao
Ningning Mi
Mingzhen Bai
Haidong Ma
Chao Zhang
Yawen Lu
Jinyu Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1217306

15,749 views
24 citations

Review

Published on 13 Jul 2023

Advances in natural compound-based nanomedicine and the interaction with gut microbiota in ulcerative colitis therapy

in Gastrointestinal and Hepatic Pharmacology

Jinlan Zhang
Shuhui Sun
Huan Chen
Yifan Feng
Ying Li
Zhengqi Dong

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1197144

3,817 views
9 citations

Editorial

Published on 13 Jul 2023

Editorial: Advances in the potential treatments of gastrointestinal and liver diseases: addressing the public health burden

in Gastrointestinal and Hepatic Pharmacology

Adina Turcu-Stiolica
Maria Dimitrova
Mariana Jinga

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1253069

1,005 views

Retraction

Published on 07 Jul 2023

Retraction: Melatonin attenuates dysregulation of the circadian clock pathway in mice with CCl4-induced fibrosis and human hepatic stellate cells

in Gastrointestinal and Hepatic Pharmacology

Frontiers Editorial Office

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1252194

2,056 views